164 related articles for article (PubMed ID: 7946361)
1. Null mutations of connexin32 in patients with X-linked Charcot-Marie-Tooth disease.
Bruzzone R; White TW; Scherer SS; Fischbeck KH; Paul DL
Neuron; 1994 Nov; 13(5):1253-60. PubMed ID: 7946361
[TBL] [Abstract][Full Text] [Related]
2. Connexin32 mutations associated with X-linked Charcot-Marie-Tooth disease show two distinct behaviors: loss of function and altered gating properties.
Ressot C; Gomès D; Dautigny A; Pham-Dinh D; Bruzzone R
J Neurosci; 1998 Jun; 18(11):4063-75. PubMed ID: 9592087
[TBL] [Abstract][Full Text] [Related]
3. Functional alterations in gap junction channels formed by mutant forms of connexin 32: evidence for loss of function as a pathogenic mechanism in the X-linked form of Charcot-Marie-Tooth disease.
Abrams CK; Freidin MM; Verselis VK; Bennett MV; Bargiello TA
Brain Res; 2001 May; 900(1):9-25. PubMed ID: 11325342
[TBL] [Abstract][Full Text] [Related]
4. Altered assembly of gap junction channels caused by COOH-terminal connexin32 mutants of CMTX.
Barrio LC; Castro C; Gómez-Hernandez JM
Ann N Y Acad Sci; 1999 Sep; 883():526-9. PubMed ID: 10586291
[No Abstract] [Full Text] [Related]
5. Changes in permeability caused by connexin 32 mutations underlie X-linked Charcot-Marie-Tooth disease.
Oh S; Ri Y; Bennett MV; Trexler EB; Verselis VK; Bargiello TA
Neuron; 1997 Oct; 19(4):927-38. PubMed ID: 9354338
[TBL] [Abstract][Full Text] [Related]
6. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
7. Connexin channels in Schwann cells and the development of the X-linked form of Charcot-Marie-Tooth disease.
Ressot C; Bruzzone R
Brain Res Brain Res Rev; 2000 Apr; 32(1):192-202. PubMed ID: 10751670
[TBL] [Abstract][Full Text] [Related]
8. Voltage opens unopposed gap junction hemichannels formed by a connexin 32 mutant associated with X-linked Charcot-Marie-Tooth disease.
Abrams CK; Bennett MV; Verselis VK; Bargiello TA
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3980-4. PubMed ID: 11891346
[TBL] [Abstract][Full Text] [Related]
9. Mutations in connexin 32: the molecular and biophysical bases for the X-linked form of Charcot-Marie-Tooth disease.
Abrams CK; Oh S; Ri Y; Bargiello TA
Brain Res Brain Res Rev; 2000 Apr; 32(1):203-14. PubMed ID: 10751671
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of connexin-32 mutants associated with X-linked dominant Charcot-Marie-Tooth disease.
Wang HL; Chang WT; Yeh TH; Wu T; Chen MS; Wu CY
Neurobiol Dis; 2004 Mar; 15(2):361-70. PubMed ID: 15006706
[TBL] [Abstract][Full Text] [Related]
11. The role of the gap junction protein connexin32 in the pathogenesis of X-linked Charcot-Marie-Tooth disease.
Scherer SS; Bone LJ; Deschênes SM; Abel A; Balice-Gordon RJ; Fischbeck KH
Novartis Found Symp; 1999; 219():175-85; discussion 185-7. PubMed ID: 10207904
[TBL] [Abstract][Full Text] [Related]
12. X-linked Charcot-Marie-Tooth disease and connexin32.
Fischbeck KH; Abel A; Lin GS; Scherer SS
Ann N Y Acad Sci; 1999 Sep; 883():36-41. PubMed ID: 10586227
[TBL] [Abstract][Full Text] [Related]
13. X-linked dominant Charcot-Marie-Tooth neuropathy: clinical, electrophysiological, and morphological phenotype in four families with different connexin32 mutations(1).
Senderek J; Hermanns B; Bergmann C; Boroojerdi B; Bajbouj M; Hungs M; Ramaekers VT; Quasthoff S; Karch D; Schröder JM
J Neurol Sci; 1999 Aug; 167(2):90-101. PubMed ID: 10521546
[TBL] [Abstract][Full Text] [Related]
14. Connexin mutations in X-linked Charcot-Marie-Tooth disease.
Bergoffen J; Scherer SS; Wang S; Scott MO; Bone LJ; Paul DL; Chen K; Lensch MW; Chance PF; Fischbeck KH
Science; 1993 Dec; 262(5142):2039-42. PubMed ID: 8266101
[TBL] [Abstract][Full Text] [Related]
15. Connexin 32 mutations from X-linked Charcot-Marie-Tooth disease patients: functional defects and dominant negative effects.
Omori Y; Mesnil M; Yamasaki H
Mol Biol Cell; 1996 Jun; 7(6):907-16. PubMed ID: 8816997
[TBL] [Abstract][Full Text] [Related]
16. Arginine-164-tryptophan substitution in connexin32 associated with X linked dominant Charcot-Marie-Tooth disease.
Oterino A; Montón FI; Cabrera VM; Pinto F; Gonzalez A; Lavilla NR
J Med Genet; 1996 May; 33(5):413-5. PubMed ID: 8733054
[TBL] [Abstract][Full Text] [Related]
17. X-linked dominant Charcot-Marie-Tooth disease: nerve biopsies allow morphological evaluation and detection of connexin32 mutations (Arg15Trp, Arg22Gln).
Senderek J; Bergmann C; Quasthoff S; Ramaekers VT; Schröder JM
Acta Neuropathol; 1998 May; 95(5):443-9. PubMed ID: 9600589
[TBL] [Abstract][Full Text] [Related]
18. X-linked dominant Charcot-Marie-Tooth neuropathy (CMTX): new mutations in the connexin32 gene.
Ressot C; Latour P; Blanquet-Grossard F; Sturtz F; Duthel S; Battin J; Corbillon E; Ollagnon E; Serville F; Vandenberghe A; Dautigny A; Pham-Dinh D
Hum Genet; 1996 Aug; 98(2):172-5. PubMed ID: 8698335
[TBL] [Abstract][Full Text] [Related]
19. New connexin32 mutations associated with X-linked Charcot-Marie-Tooth disease.
Bone LJ; Dahl N; Lensch MW; Chance PF; Kelly T; Le Guern E; Magi S; Parry G; Shapiro H; Wang S
Neurology; 1995 Oct; 45(10):1863-6. PubMed ID: 7477983
[TBL] [Abstract][Full Text] [Related]
20. Analysis of gap junction assembly using mutated connexins detected in Charcot-Marie-Tooth X-linked disease.
Martin PE; Mambetisaeva ET; Archer DA; George CH; Evans WH
J Neurochem; 2000 Feb; 74(2):711-20. PubMed ID: 10646523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
